title: What happens after prothrombin complex concentrate administration?
authors.forename: Sarah
authors.initials: S
authors.lastname: Horton
authors.forename: Rachel
authors.initials: R
authors.lastname: Heath
authors.forename: Anthony
authors.initials: A
authors.lastname: Houghton
authors.forename: Vanessa
authors.initials: V
authors.lastname: Martlew
authors.forename: Jecko
authors.initials: J
authors.lastname: Thachil
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000009:adverse effects; D002985:Clinical Protocols / Q000592:standards; D003029:Coagulants / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology / Q000517:prevention & control; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D019934:International Normalized Ratio / Q000379:methods / Q000592:standards; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D006113:United Kingdom; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003029:Coagulants; C025667:prothrombin complex concentrates; D014859:Warfarin